Testosterone therapy does not appear to worsen outcomes in men with COVID-19

In this interview, Amarnath Rambhatla, MD, discusses findings from the Journal of Sexual Medicine study, COVID-19 infection in men on testosterone therapy, for which he served as a study author. Rambhatla is director of men’s health at the Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan.

More videos:

Setting expectations in patients with prostate cancer receiving HIFU​

HIFU for prostate cancer: How it works, criteria for treatment, and contraindications​

Attorney Kenton H. Steele, Esq on the medico-legal dangers of friendly prescribing​